| Value | ₹0.02 Cr |
|---|
BSE filing, NSE: ASTRAZEN. Summary written from the filing by ALFA Finder's alert engine.
AstraZeneca Pharma India Ltd: key numbers
- Share price
- ₹6,279.50
- Market cap
- ₹15,699 Cr
- Revenue (annual)
- ₹2,276 Cr
- Net profit (annual)
- ₹187.5 Cr
- P/E (TTM)
- 92.5×Sector 46.1×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from AstraZeneca Pharma India Ltd
All →AstraZeneca Pharma India Capacity Expansion
AstraZeneca Pharma India inaugurated a new corporate office in Mumbai, covering 25,600 sq ft. This expansion strengthens the company's commercial operations and footprint in India.
- office space
- 25600.0 sq ft
AstraZeneca Pharma India Annual General Meeting
AstraZeneca Pharma India Ltd declared the voting results of its postal ballot, confirming the appointment and designation change of certain non-executive directors.
AstraZeneca Pharma India Other Announcement
NSE Sustainability Ratings and Analytics assigned AstraZeneca Pharma India an ESG rating of 73 for FY 2025-26. The rating was independently prepared without company engagement.
AstraZeneca Pharma India Legal & Regulatory
AstraZeneca Pharma India Limited received an order from the ROC, Bengaluru, imposing a total penalty of ₹0.03 Crore for a delayed filing. The company is evaluating next steps.
- Value
- ₹0.03 Cr
- From
- Registrar of Companies, Bengaluru, Karnataka
AstraZeneca Pharma India Management Change
AstraZeneca Pharma India's Dr. Sandeep Arora resigned as Director, Medical Affairs, effective September 15, 2026. The company is seeking a suitable replacement for the position.
AstraZeneca Pharma India Other Announcement
AstraZeneca Pharma India reported receiving an ESG rating of 64 from Crisil ESG Ratings. The assessment was independently prepared using publicly available information.
Other legal & regulatory announcements
All →Delta Corp Legal & Regulatory
CGST Goa rectified GST orders reducing Delta Corp's differential demand to ₹28.99 Crore for casino-entry packages (2017-22). Company may appeal the remaining penalty within prescribed timelines.
- Value
- ₹28.99 Cr
Jammu & Kashmir Bank Legal & Regulatory
J&K Bank announces CBIC GST circular validates its FTP position, supporting quashing of two demand orders. Total GST liability at stake is ₹8,330.87 Crore.
- Value
- ₹8,331 Cr
Shera Energy Legal & Regulatory
Shera Energy disclosed an NSE advisory letter for ICDR Reg 160(f) non-compliance on delayed warrant conversion filing. No monetary penalty was levied.
Abril Paper Tech Legal & Regulatory
April Paper Tech disclosed a personal hearing on 02 Nov 2026 on a GST show-cause notice alleging short tax payment. The company considers the demand unmaintainable and expects no financial impact.
Delta Corp Legal & Regulatory
Delta Corp disclosed GST rectification orders dated October 28, 2026. They cut aggregate differential GST demand by about INR 8.12 Crore, to INR 28.99 Crore.
- Value
- ₹8.12 Cr
Bharti Airtel Legal & Regulatory
Bharti Airtel disclosed a DoT Karnataka penalty of Rs. 2,14,000 for subscriber verification norm violations. The company will pay the penalty without contest.
- Value
- ₹0.02 Cr